ALB and lymphopenia: Even though the cause of death in our cohort was mostly due to progressive disease imitated in corticosteroid use and high CRP/Albumin, assessing the effect of treatment-related lymphopenia on survival in patients with better prognosis at early stage of lung cancer is encouraging.